Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Farxiga and Zynquista are recommended for approval for people with type 1 diabetes in Europe with emphasis on DKA safety; EMA approval likely in coming months and hope...
An inside look into former Aetna CEO Mark Bertolini's book, "Mission Driven Leadership: My Journey as a Radical Capitalist"
Companion Medical's InPen is now available in 60,000 retail pharmacies across the United States
Control-IQ hybrid closed loop coming in summer 2019; paired app coming soon to the US; plans for the t:sport “patch” pump; and t:slim X2 pump launched outside the US
We asked diabetes experts for their advice for people with diabetes. They emphasized being your own advocate, finding community, technology, and always asking questions
Xeris’ Glucagon Rescue Pen, designed as an auto-injector, features a ready-to-use liquid glucagon – a safer and more convenient treatment option for severe hypoglycemia
Diabeloop’s automated insulin delivery system includes the Kaleido insulin pump, an Android controller, and the Dexcom G6 CGM; it is the second hybrid closed loop...
From clinical expertise and personal experience as a type 1, Dr. Sherr shares valuable (and exciting) perspectives on diabetes treatments.
How Jamie Kurtzig, a high school student using a DIY automated insulin delivery system, manages her type 1 diabetes
AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper
The importance of sleep for teens with diabetes. Plus, key sleep strategies from young adults living with diabetes!
New product details, pictures, and study timing updates on Beta Bionics’ iLet and Bigfoot’s Loop and Inject systems from Friends for Life 2018
How Kerri Sparling navigates CGM sharing with friends and family and how it’s helped her feel less self-conscious about her numbers
To commemorate World Obesity Day, we are raising attention on terribly stigmatizing language around obesity and weight
Zynquista was not approved by the FDA; Complete Response Letter suggests the FDA is weighing safety concerns of the SGLT-1/2 dual inhibitor for type 1 diabetes
Updates to the Clarity app allow G5 and G6 CGM users to set a daily time-in-range goal and be notified when it is reached, awesome Bright Spots pattern recognition in...
Contribute data to a new study on how overnight blood sugars affect sleep, activity, and mental state; four-week “virtual” trial recruiting people with type 1 on Dexcom...
The latest on Dexcom’s work with Verily to make a more simple and accessible CGM; also, the “Pro Q” professional CGM and insulin dosing advice for people on multiple...
Eylea can help reduce the risk of vision loss, a common complication of diabetes
The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes

Pages